ESR1 and PGR Gene Promoter Methylation and Correlations with Estrogen and Progesterone Receptors in Ductal and Lobular Breast Cancer |
Medina-Jaime, Alma Delia
(Health Services of Durango SSD)
Reyes-Vargas, Francianella (Cancer State Center of the Ministry of Health of Durango SSD) Martinez-Gaytan, Victoria (UMAE 23 IMSS Monterrey) Zambrano-Galvan, Graciela (Faculty of Dentistry UJED) Portillo-DelCampo, Eduardo (Espana Autonomous University of Durango) Burciaga-Nava, Jorge Alberto (Faculty of Medicine and Nutrition UJED) Reyes-Romero, Miguel (Faculty of Medicine and Nutrition UJED) Sifuentes-Alvarez, Antonio (Faculty of Medicine and Nutrition UJED) |
1 | Mc Cormack O, Harrison M, Kerin MJ, McCann A (2007). Role of the progesterone receptor (PR) and the PR isoforms in breast cancer. Crit Rev Oncog, 13, 283-301. DOI ScienceOn |
2 | Sturgeon SR, Balasubramanian R, Schairer C, et al (2012). Detection of promoter methylation of tumor suppressor genes in serum DNA of breast cancer cases and benign breast disease controls. Epigenetics, 7, 1258-67. DOI |
3 | Wessa P (2011) Free statistics software, office for research development and education, version 1.23-r7, available in www.wessa.net/.). |
4 | Herman JG, Graff JR, Myohanen S, et al (1996) Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA, 93, 9821-6. DOI ScienceOn |
5 | Knutson TP, Lange CA (2013). Tracking progesterone receptor-mediated actions in breast cancer. Pharmacol Ther, [Epub ahead of print]. |
6 | Lapidus RG, Nass SJ, Butash KA, et al (1998). Mapping of ER gene CpG island methylation-specific polymerase chain reaction. Cancer Res, 58, 2515-9. |
7 | Parrella P (2010). Epigenetic signatures in breast cancer: clinical perspective. Breast Care, 5, 66-73. DOI ScienceOn |
8 | Purdie CA, Quinlan P, Jordan LB, et al (2014). Progesterone receptor expression is an independent prognostic variable in early breast cancer: a population-based study. Br J Cancer, 110, 565-72. DOI ScienceOn |
9 | Radisky DC, Bissell MJ (2007). NF-kappaB links oestrogen receptor signalling and EMT. Nat Cell Biol, 9, 361-3. DOI ScienceOn |
10 | Ramezani F, Salami S, Omrani MD, Maleki D (2012). CpG island methylation profile of estrogen receptor alpha in Iranian females with triple negative or non-triple negative breast cancer: new marker of poor prognosis. Asian Pac J Cancer Prev, 13, 451-7. 과학기술학회마을 DOI ScienceOn |
11 | Renoir JM, Marsaud V, Lazennec G (2013). Estrogen receptor signaling as a target for novel breast cancer therapeutics. Biochem Pharmacol, 85, 449-65. DOI ScienceOn |
12 | Sasaki M, Dharia A, Oh BR, et al (2001). Progesterone receptor B gene inactivation and CpG hypermethylation in human uterine endometrial cancer. Cancer Res, 61, 97-102. |
13 | Castoria G, Migliaccio A, Giovannelli P, Auricchio F (2010). Cell proliferation regulated by estradiol receptor: therapeutic implications. Steroids, 75, 524-7. DOI ScienceOn |
14 | Allred DC (2010). Issues and updates: evaluating estrogen receptor-alpha, progesterone receptor, and HER2 in breast cancer. Mod Pathol, 23, 52-59. DOI ScienceOn |
15 | Baylin SB, Jones PA (2011). A decade of exploring the cancer epigenome-biological and translational implications. Nat Rev Cancer, 11, 726-34. DOI ScienceOn |
16 | Cancer Genome Atlas Network (2012). Comprehensive molecular portraits of human breast tumours. Nature Oct, 4, 49061-70. |
17 | Esteller M (2008). Epigenetics in cancer. N Engl J Med, 358, 1148-59. DOI ScienceOn |
18 | Feinberg AP, Tycko B (2004). The history of cancer epigenetics. Nat Rev Cancer, 4, 143-53. DOI ScienceOn |
19 | Goldhirsch A, Winer EP, Coates AS, et al (2013). Personalizing the treatment of women with early breast cancer: highlights of the St gallen international expert consensus on the primary therapy of early breast cancer 2013. Ann Oncol, 24, 2206-23. DOI ScienceOn |
20 | Gaudet MM, Campan M, Figueroa JD, et al (2009). DNA hypermethylation of ESR1 and PGR in breast cancer: pathologic and epidemiologic associations. Cancer Epidemiol Biomarkers Prev, 18, 3036-43. DOI ScienceOn |
21 | Hammond ME, Hayes DF, Dowsett M, et al (2010). American society of clinical oncology/college of american pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol, 28, 2784-95. DOI ScienceOn |
22 | Heichman KA, Warren JD (2012). DNA methylation biomarkers and their utility for solid cancer diagnostics. Clin Chem Lab Me, 50, 1707-21. |